Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Idera Pharmaceuticals Inc (NASDAQ:IDRA)

1.74
Delayed Data
As of Feb 17
 +0.06 / +3.57%
Today’s Change
1.19
Today|||52-Week Range
3.33
+16.00%
Year-to-Date
No recent news for Idera Pharmaceuticals Inc.

Today’s Trading

Previous close1.68
Today’s open1.68
Day’s range1.66 - 1.79
Volume1,217,306
Average volume (3 months)1,076,673
Market cap$256.9M
Dividend yield--
Data as of 4:00pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)+10.64%
Earnings growth (this year)+13.49%
Earnings growth (next 5 years)--
Revenue growth (last year)+241.10%
P/E ratioNM
Price/Sales1,428.25
Price/Book2.52

Competitors

 Today’s
change
Today’s
% change
TGTXTG Therapeutics Inc-0.05-1.06%
ZGNXZogenix Inc-0.25-2.39%
MNKDMannKind Corp-0.01-1.96%
TTPHTetraphase Pharmaceu...+0.09+1.69%
Data as of 3:59pm ET, 02/17/2017

Financials

Next reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$249.0K
Annual profit (last year)-$48.6M
Net profit margin-19,500.00%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Vin Milano
CFO, Treasurer &
Senior Vice President-Operations
Louis J. Arcudi
Corporate headquarters
Cambridge, Massachusetts

Forecasts


Search for Jobs